$4.220
+0.020 (+0.48%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Artiva Biotherapeutics Inc (ARTV) Moving Averages Convergence Divergence (MACD) indicator is -0.96, suggesting ARTV is Strong sell.
Artiva Biotherapeutics Inc (ARTV) 20-Day simple moving average is 5.45, while Artiva Biotherapeutics Inc (ARTV) share price is $—, making it Sell.
Artiva Biotherapeutics Inc (ARTV) 60-Day simple moving average is 8.19, while Artiva Biotherapeutics Inc (ARTV) share price is $—, making it Sell.
Technical Analysis for ARTV
AI Technical ARTVAs of 2026-11-02, the technical board for Artiva Biotherapeutics Inc (ARTV) reads strong sell: 2 indicators are flashing buy, 8 are indicating sell, and 3 are neutral. Price at $4.22 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 20.361, MACD stands at -0.965 (Sell), Stochastic %K stands at 6.083 (Buy), Stochastic %D stands at 6.853 and CCI stands at -88.831.
ARTV trades below the 60-day SMA (8.19) and below the 200-day SMA (8.02). Immediate resistance sits at Classic R1 5.90, then R2 7.20. Support sits at Classic S1 3.65, then S2 2.70.
Artiva Biotherapeutics Inc (ARTV) Support & Resistance Level
Artiva Biotherapeutics Inc (ARTV) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 20.361 |
| STOCHk_14_3_3 | 6.083 |
| STOCHd_14_3_3 | 6.853 |
| CCI_20 | -88.831 |
| AO_5_34 | -2.019 |
| MOM_10 | -2.120 |
| MACD_12_26_9 | -0.965 |
Artiva Biotherapeutics Inc (ARTV) Relative Strength Index (RSI_14) is 20.361, creating a Buy signal.
Artiva Biotherapeutics Inc (ARTV) Stochastic %K is 6.083, creating a Buy signal.
Artiva Biotherapeutics Inc (ARTV) Stochastic %D is 6.853, creating a Buy signal.
Artiva Biotherapeutics Inc (ARTV) CCI_20 is -88.831, creating a Neutral signal.
Artiva Biotherapeutics Inc (ARTV) Awesome Oscillator (AO) is -2.019, creating a Sell signal.
Artiva Biotherapeutics Inc (ARTV) Momentum (MOM) is -2.120, creating a Sell signal.
Artiva Biotherapeutics Inc (ARTV) Moving Average Convergence Divergence (MACD) is -0.965, creating a Sell signal.
Artiva Biotherapeutics Inc (ARTV) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 4.176 | Buy |
| MA_10 | 4.596 | Sell |
| MA_20 | 5.446 | Sell |
| MA_60 | 8.188 | Sell |
| MA_200 | 8.018 | Sell |
| MA_250 | 7.213 | Sell |
Artiva Biotherapeutics Inc (ARTV) 5-Day simple moving average is 4.176, while Artiva Biotherapeutics Inc (ARTV) share price is $, making it a Buy.
Artiva Biotherapeutics Inc (ARTV) 10-Day simple moving average is 4.596, while Artiva Biotherapeutics Inc (ARTV) share price is $, making it a Sell.
Artiva Biotherapeutics Inc (ARTV) 20-Day simple moving average is 5.446, while Artiva Biotherapeutics Inc (ARTV) share price is $, making it a Sell.
Artiva Biotherapeutics Inc (ARTV) 60-Day simple moving average is 8.188, while Artiva Biotherapeutics Inc (ARTV) share price is $, making it a Sell.
Artiva Biotherapeutics Inc (ARTV) 200-Day simple moving average is 8.018, while Artiva Biotherapeutics Inc (ARTV) share price is $, making it a Sell.
Artiva Biotherapeutics Inc (ARTV) 250-Day simple moving average is 7.213, while Artiva Biotherapeutics Inc (ARTV) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.